abagovomab 28
abciximab 27
abituzumab 23
abrilumab 22
actoxumab 17
adalimumab 21
aducanumab 14
afasevikumab 17
alacizumab_pegol 12
alemtuzumab 28
alirocumab 23
amatuximab 43
andecaliximab 23
anifrolumab 21
anrukinzumab 20
aprutumab 18
aprutumab_ixadotin 18
arcitumomab 24
ascrinvacumab 8
atezolizumab 16
atinumab 16
avelumab 15
basiliximab 29
bavituximab 39
begelomab 27
benralizumab 30
bevacizumab_beta 21
bezlotoxumab 17
bimagrumab 20
bleselumab 14
blinatumomab 33
blosozumab 30
bococizumab 18
brazikumab 18
brentuximab_vedotin 35
briakinumab 19
brodalumab 12
brolucizumab 27
brontictuzumab 29
burosumab 21
cabiralizumab 29
camrelizumab 15
canakinumab 23
cantuzumab_ravtansin 46
carlumab 15
carotuximab 29
cergutuzumab_amunaleukin2 27
cergutuzumab_amunaleukin 27
certolizumab_pegol 26
cetiximab 46
citatuzumab_bogatox 29
cixutumumab 29
clivatuzumab_tetraxetan 23
codrituzumab 31
conatumumab 11
concizumab 29
crenezumab 22
crizanlizumab 27
crotedumab 21
dacetuzumab 25
daclizumab 18
dalotuzumab 34
dapirolizumab_pegol 27
daratumumab 14
dectrekumab 10
demcizumab 25
denosumab 10
depatuxizumab 24
depatuxizumab_mafodotin 24
dezamizumab 25
dinutuximab 39
diridavumab 26
domagrozumab 17
drozitumab 18
duligotuzumab 21
durvalumab 12
dusigitumab 20
efalizumab 35
efungumab 31
eldelumab 17
elezanumab 24
elgemtumab 14
elotuzumab 19
emactuzumab 20
emapalumab 26
emibetuzumab 19
enavatuzumab 25
enfortumab_vedotin 15
enoblituzumab 20
enokizumab 25
enoticumab 20
ensituximab 36
eptinezumab 19
erenumab 23
etaracizumab 15
etrolizumab 23
evinacumab 23
evolocumab 19
farletuzumab 8
fasinumab 26
fezakinumab 23
fibatuzumab 13
ficlatuzumab 25
firivumab 37
flanvotumab 21
fletikumab 23
foralumab 14
foravirumab 16
fremanezumab 29
fresolimumab 19
fulranumab 20
futuximab 28
galcanezumab 22
ganitumab 27
gantenerumab 14
gemetuzumab 33
gemtuzumab2 28
gemtuzumab 25
gevokizumab 21
girentuximab 29
glembatumumab 18
glembatumumab_vedotin 18
guselkumab 23
ibalizumab 29
ibritumomab 37
icrucumab 12
idarucizumab 35
ifabotuzumab 13
imalumab 19
imgatuzumab 23
inclacumab 21
indatuximab_ravtansin 37
indusatumab 18
inebilizumab 25
intetumumab 14
iodine_girentuximab 30
ipilimumab 7
iratumumab 11
isatuximab 37
itolizumab 27
ixekizumab 32
labetuzumab_govitecan 21
lambrolizumab 27
lampalizumab 27
lanadelumab 19
landogrozumab 19
laprituximab 30
lebrikizumab 39
lendalizumab 26
lenzilumab 19
lifastuzumab_vedotin 26
ligelizumab 23
lilotomab 40
lirilumab 25
lodelcizumab 19
lokivetmab 25
lorvotuzumab_mertansin 26
lucatumumab 30
lumretuzumab 21
lupartumab 17
lutikizumab 21
margetuximab 33
milatuzumab 40
mirvetuximab 34
mirvetuximab_soravtansin 34
modotuximab 41
mogamulizumab 31
monalizumab 22
motavizumab 35
moxetumomab_pasudotox 32
namilumab 25
naratuximab 31
naratuximab_emtansin 31
narnatumab 16
navicixizumab2 28
navicixizumab 28
navivumab 35
necitumumab 12
nemolizumab 30
nesvacumab 18
nivolumab 13
obiltoxaximab 24
obinutuzumab 36
ocaratuzumab 28
ofatumumab 20
olaratumab 19
olokizumab 26
omalizumab 19
onartuzumab 23
ontuxizumab 30
opicinumab 15
orticumab 16
otelixizumab 38
oxelumab 13
ozanezumab 34
pamrevlumab 13
panobacumab 31
parsatuzumab 29
pasotuxizumab 23
pateclizumab 20
patritumab 23
pembrolizumab 27
perakizumab 25
pidilizumab 19
pinatuzumab_vedotin 19
plozalizumab 33
pogalizumab 25
polatuzumab_vedotin 22
ponezumab 39
prezalumab 16
pritoxaximab 40
quilizumab 21
racotumomab 29
radretumab 16
ralpancizumab 23
ramucirumab 14
ranevetmab 30
ranibizumab 24
refanezumab 23
remtolumab 21
rilotumumab 15
rinucumab 19
risankizumab 33
rituximab 23
rivabazumab 23
robatumumab 20
roledumab 35
romosozumab 24
rontalizumab 24
rosmantuzumab 24
rozanolixizumab 22
sacituzumab 30
sacituzumab_govitecan 30
samalizumab 28
sapelizumab 24
sarilumab 18
secukinumab 15
seribantumab 18
setoxaximab 43
sifalimumab 12
siltuximab 25
simtuzumab 30
sirukumab 12
solanezumab 27
solitomab 30
stamulumab 19
suptavumab 22
suvizumab 20
tabalumab 12
tadocizumab 21
tamtuvetmab 34
tanezumab 23
tarextumab 13
tavolixizumab 19
telisotuzumab 31
teplizumab 23
tesidolumab 24
tezepelumab 25
tigatuzumab 18
tildrakizumab 23
timolumab 17
tisotumab 15
tosatoxumab 41
tositumomab 34
tralokinumab 25
trastuzumab 24
tregalizumab 24
trevogrumab 14
ublituximab 31
urelumab 20
ustekinumab 29
utomilumab 26
vadastuximab 26
vadastuximab_talirin 26
vandortuzumab_vedotin 20
vantictumab 20
vanucizumab2 21
vanucizumab 30
varlilumab 17
vatelizumab 22
vedolizumab 27
veltuzumab 18
vesencumab 12
vorsetuzumab 21
vorsetuzumab_mafodotin 21
vunakizumab 32
xentuzumab 20
zatuximab 41
